Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,986
Closed -$627K 182
2020
Q4
$627K Sell
2,986
-14,764
-83% -$3.24M 0.04% 124
2020
Q3
$3.85M Sell
17,750
-341
-2% -$74.2K 0.27% 46
2020
Q2
$3.85M Sell
18,091
-8,446
-32% -$1.8M 0.26% 55
2020
Q1
$5.6M Buy
26,537
+3,179
+14% +$667K 0.83% 35
2019
Q4
$4.9M Buy
23,358
+7,418
+47% +$1.54M 0.24% 41
2019
Q3
$3.28M Buy
15,940
+205
+1% +$42.1K 0.19% 49
2019
Q2
$3.21M Buy
15,735
+1,021
+7% +$208K 0.15% 50
2019
Q1
$2.97M Buy
14,714
+10,606
+258% +$2.12M 0.22% 51
2018
Q4
$805K Buy
4,108
+1,608
+64% +$315K 0.11% 85
2018
Q3
$485K Buy
+2,500
New +$484K 0.04% 120

Other funds holding CLNN

Mizuho Securities USA's CLNN Position: Q1 2021 in Review

Mizuho Securities USA sold out of Clene (CLNN) in Q1 2021, closing a stake of 2,986 shares — an estimated $627K sold.

Mizuho Securities USA first reported a position in CLNN in Q3 2018 and held it in 10 quarters. The position peaked at $5.6M in Q1 2020. 24 funds tracked by Wall St. Rank hold CLNN as of Q1 2021.

  • Mizuho Securities USA reported no remaining Clene position as of Q1 2021 after selling out during the quarter.
  • Mizuho Securities USA sold 2,986 Clene shares in Q1 2021, an estimated $627K.
  • Mizuho Securities USA first reported a position in Clene in Q3 2018 and held it in 10 quarters.
  • Mizuho Securities USA's Clene position peaked at $5.6M in Q1 2020.
  • 24 funds tracked by Wall St. Rank held Clene as of Q1 2021.

Based on Mizuho Securities USA's 13F filing for Q1 2021, filed 28 Apr 2021.